ORENCIA is a prescription medicine that reduces signs and symptoms in:\u00a0 \uf0b7 adults with moderate to severe rheumatoid arthritis (RA), including those who have not been helped enough by other medicines for RA. ORENCIA may prevent further damage to your bones and joints and may help your ability to perform daily activities. In adults, ORENCIA may be used alone or with other RA treatments other than tumor necrosis factor (TNF) antagonists. \uf0b7 children and adolescents 6 years of age and older with moderate to severe polyarticular juvenile idiopathic arthritis (JIA). ORENCIA may be used alone or with methotrexate. Active ingredient:\u00a0 abatacept, Intravenous inactive ingredients:\u00a0 maltose, monobasic sodium phosphate, sodium chloride for administration, Subcutaneous inactive ingredients: sucrose, poloxamer 188, monobasic sodium phosphate monohydrate, dibasic sodium phosphate anhydrous, water for injection.<\/p>\n
If abatacept for injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
ORENCIA (abatacept for injection) for intravenous use injection<\/p>\n","protected":false},"excerpt":{"rendered":"
ORENCIA is a selective T cell costimulation modulator indicated for: Adult Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis,<\/p>\n
Approval Date:\u00a0 2005 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cAbatacept for Injection\u201d based on the information you provide.<\/strong><\/p>\n
\nProprietary Name:\u00a0 ORENCIA (abatacept) for injection
\nActive Ingredient(s):\u00a0 abatacept
\nFDA-approved use:
\nDosage Form:\u00a0 250 mg lyophilized powder in a single-use vial for intravenous infusion (3) \uf0b7 125 mg\/mL solution in a single-dose prefilled syringe
\nMedicine Approved By: Food and Drug Administration (FDA)
\nManufacturer:
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n